Amgen And MSD announce collaboration to evaluate investigational combination treatment for advanced melanoma
5 February 2014 | By Amgen
Amgen and MSD announced that they have entered into an agreement through a subsidiary to evaluate the safety and efficacy of talimogene laherparepvec...